Stocks
Vanda Pharmaceuticals (VNDA) EBITDA US GAAP (year values) |
||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
| EBITDA, bln rub | ? | 24.3 | 30.1 | 43.6 | 7.85 | -10.9 | -21.1 | |
| Changes by years, y/y, % | +5% | +24% | +45% | -82% | -239% | |||
Vanda Pharmaceuticals. EBITDA US GAAP, bln rub
Vanda Pharmaceuticals. EBITDA US GAAP, changes, %
Vanda Pharmaceuticals. EBITDA US GAAP, sum by quarters, bln rub
Vanda Pharmaceuticals (VNDA) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| EBITDA, bln rub | ? | 2.67 | -2.49 | -5.62 | -5.94 | -7.01 | -21.1 | |
| Changes by years, y/y, % | -138% | -160% | -231% | -185% | -362% | |||
| Changes by quarters, q/q, % | -62% | -193% | +126% | +6% | +18% | |||
